Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice.

Introduction: N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high sensitivity cardiac troponin T (hs-cTnT) improve prediction of incident heart failure (HF) and are cross-sectionally associated with left ventricular (LV) remodeling, but their associations with changes in cardiac structure and function are unclear. Hypothesis: Concentrations of NT-proBNP and hs-cTnT associate with 6-year change in cardiac structure in older adults. Methods: We studied 1,916 participants aged 67-88 in the ARIC Study free of overt cardiovascular disease at baseline (study Visit 5; 2011-13). We quantified the associations of baseline NT-proBNP and hs-cTnT with subsequent changes in LV structure and systolic and diastolic function assessed by echocardiography over a median of 6.6 (IQR 6.1-7.0) years using multivariable linear regression and restricted cubic spline models. Models adjusted for demographics, systolic blood pressure, heart rate, body mass index, diabetes, hypertension, kidney function, and the baseline echocardiographic value of interest at Visit 5. Results: Mean age was 75±4 years, 60% were female, 23% were black, median hs-cTnT was 9 (IQR 6-13) ng/L and NT-proBNP was 88 (50-157) ng/L at Visit 5. In adjusted models, higher hs-cTnT was modestly associated with 6-year increase in LV wall thickness (p=0.02) but not with changes in LV function. In contrast, higher NT-proBNP at Visit 5 was associated with 6-year increase in LV mass, decline in LV systolic function (ejection fraction, longitudinal and circumferential strain), and worsening of diastolic function (left atrium volume, E/e’, tricuspid regurgitation peak velocity) (all p<0.01, Figure ). These associations were non-linear. Conclusions: Higher NT-proBNP, but not hs-cTnT, concentrations are associated with greater declines in LV systolic and diastolic function over ~6 years in late life.

Download Full-text

Cardiac structure and function in response to a multi-stage marathon over 4486 km

European Journal of Preventive Cardiology ◽

10.1177/2047487319885035 ◽

2019 ◽

pp. 204748731988503 ◽

Cited By ~ 2

Author(s):

Christopher Klenk ◽

Horst Brunner ◽

Thomas Nickel ◽

Florian Sagmeister ◽

Atilgan Yilmaz ◽

...

Keyword(s):

Left Ventricular Mass ◽

Cardiac Troponin ◽

Troponin I ◽

Left Ventricular ◽

Structure And Function ◽

Cardiac Troponin I ◽

Cardiac Structure ◽

Cardiac Structure And Function ◽

And Function

Aims To investigate whether participation in the Trans Europe Foot Race 2009 (TEFR), an ultramarathon race held over 64 consecutive days and 4486 km, led to changes in cardiac structure and function. Methods Cardiac magnetic resonance imaging was performed in 20 of 67 participating runners (two women; mean ± SD age 47.8 ± 10.4 years) at three time points (baseline scan at 294 ± 135 km (B), scan two at 1735 ± 86 km (T1) and scan three at 3370 ± 90 km (T2)) during the TEFR. Imaging included an assessment of left ventricular structure (mass) and function (strain). In parallel, cardiac troponin I, NT-pro-BNP, myostatin and GDF11 were determined in venous blood samples. A subsample of ten runners returned for a follow-up scan eight months after the race. Results Left ventricular mass increased significantly (B, 158.5 ± 23.8 g; T1, 165.1 ± 23.2 g; T2, 167 ± 24.6 g; p < 0.001) over the course of the race, although no significant change was seen in the remaining structural and functional parameters. Serum concentrations of cardiac troponin I and NT-proBNP significantly increased 1.5 - and 3.5-fold, respectively, during the first measurement interval, with no further increase thereafter (cardiac troponin I, 6.8 ± 3.1 (B), 16.9 ± 10.4 (T1) and 17.1 ± 9.7 (T2); NT-proBNP, 30.3 ± 22.8 (B), 135.9 ± 177.5 (T1) and 111.2 ± 87.3 (T2)), whereas the growth markers myostatin and GDF11 did not change. No association was observed with functional parameters, including the ejection fraction and the volume of both ventricles. The follow-up scans showed a reduction to baseline values (left ventricular mass 157 ± 19.3 g). Conclusions High exercise-induced cardiac volume load for >2 months in ultra-endurance runners results in a physiological structural adaptation with no sign of adverse cardiovascular remodelling.

Download Full-text

Relation of Impaired Glucose Tolerance to Cardiac Structure and Function: The Strong Heart Study

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)88289-7 ◽

1998 ◽

Vol 31 (2) ◽

pp. 525A-526A

Author(s):

A Ilercil

Keyword(s):

Glucose Tolerance ◽

Impaired Glucose Tolerance ◽

Structure And Function ◽

Cardiac Structure ◽

Strong Heart Study ◽

Heart Study ◽

Cardiac Structure And Function ◽

And Function

Download Full-text

Faculty Opinions recommendation of Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718180959.793489610 ◽

2014 ◽

Author(s):

Chim Lang

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Cardiac Function ◽

Structure And Function ◽

Cardiac Structure ◽

Preserved Ejection Fraction ◽

Aldosterone Antagonist ◽

Echocardiographic Study ◽

Cardiac Structure And Function ◽

And Function

Download Full-text

Impact of the severity of end-stage liver disease in cardiac structure and function

Annals of Hepatology ◽

10.1016/s1665-2681(19)31389-4 ◽

2013 ◽

Vol 12 (1) ◽

pp. 85-91 ◽

Cited By ~ 18

Author(s):

Odilson Marcos Silvestre ◽

Fernando Bacal ◽

Danusa de Souza Ramos ◽

Jose L. Andrade ◽

Meive Furtado ◽

...

Keyword(s):

Liver Disease ◽

Structure And Function ◽

Cardiac Structure ◽

End Stage Liver Disease ◽

Cardiac Structure And Function ◽

End Stage ◽

And Function

Download Full-text

Development of a semi-automated segmentation tool for high frequency ultrasound image analysis of mouse echocardiograms

Scientific Reports ◽

10.1038/s41598-021-85971-3 ◽

2021 ◽

Vol 11 (1) ◽

Author(s):

Kristi Powers ◽

Raymond Chang ◽

Justin Torello ◽

Rhonda Silva ◽

Yannick Cadoret ◽

...

Keyword(s):

Image Analysis ◽

Automated Analysis ◽

Structure And Function ◽

Ultrasound Images ◽

Cardiac Structure ◽

Short Axis ◽

Pixel Intensity ◽

Cardiac Structure And Function ◽

And Function

AbstractEchocardiography is a widely used and clinically translatable imaging modality for the evaluation of cardiac structure and function in preclinical drug discovery and development. Echocardiograms are among the first in vivo diagnostic tools utilized to evaluate the heart due to its relatively low cost, high throughput acquisition, and non-invasive nature; however lengthy manual image analysis, intra- and inter-operator variability, and subjective image analysis presents a challenge for reproducible data generation in preclinical research. To combat the image-processing bottleneck and address both variability and reproducibly challenges, we developed a semi-automated analysis algorithm workflow to analyze long- and short-axis murine left ventricle (LV) ultrasound images. The long-axis B-mode algorithm executes a script protocol that is trained using a reference library of 322 manually segmented LV ultrasound images. The short-axis script was engineered to analyze M-mode ultrasound images in a semi-automated fashion using a pixel intensity evaluation approach, allowing analysts to place two seed-points to triangulate the local maxima of LV wall boundary annotations. Blinded operator evaluation of the semi-automated analysis tool was performed and compared to the current manual segmentation methodology for testing inter- and intra-operator reproducibility at baseline and after a pharmacologic challenge. Comparisons between manual and semi-automatic derivation of LV ejection fraction resulted in a relative difference of 1% for long-axis (B-mode) images and 2.7% for short-axis (M-mode) images. Our semi-automatic workflow approach reduces image analysis time and subjective bias, as well as decreases inter- and intra-operator variability, thereby enhancing throughput and improving data quality for pre-clinical in vivo studies that incorporate cardiac structure and function endpoints.

Download Full-text

The mitral regurgitation effects of cardiac structure and function in left ventricular noncompaction

Scientific Reports ◽

10.1038/s41598-021-84233-6 ◽

2021 ◽

Vol 11 (1) ◽

Author(s):

Qing Zou ◽

Rong Xu ◽

Xiao Li ◽

Hua-yan Xu ◽

Zhi-gang Yang ◽

...

Keyword(s):

Mitral Regurgitation ◽

Nyha Class ◽

Left Ventricular ◽

Structure And Function ◽

Left Ventricular Geometry ◽

Cardiac Structure ◽

Left Ventricular Noncompaction ◽

Ventricular Noncompaction ◽

Cardiac Structure And Function ◽

And Function

AbstractThis study evaluated the effects of mitral regurgitation (MR) on cardiac structure and function in left ventricular noncompaction (LVNC) patients. The clinical and cardiovascular magnetic resonance (CMR) data for 182 patients with noncompaction or hypertrabeculation from three institutes were retrospectively included. We analyzed the difference in left ventricular geometry, cardiac function between LVNC patients with and without MR. The results showed that patients with MR had a worse New York Heart Association (NYHA) class and a higher incidence of arrhythmia (P < 0.05). MR occurred in 48.2% of LVNC patients. Compared to LVNC patients without MR, the two-dimensional sphericity index, maximum/minimum end-diastolic ratio and longitudinal shortening in LVNC patients with MR were lower (P < 0.05), and the peak longitudinal strain (PLS) of the global and segmental myocardium were obviously reduced (P < 0.05). No significant difference was found in strain in LVNC patients with different degree of MR; end diastolic volume, end systolic volume, and global PLS were statistically associated with MR and NYHA class (P < 0.05), but the non-compacted to compacted myocardium ratio had no significant correlation with them. In conclusion, the presence of MR is common in LVNC patients. LVNC patients with MR feature more severe morphological and functional changes. Hypertrabeculation is not an important factor affecting structure and function at the heart failure stage.

Download Full-text

Differences between diabetic and non-diabetic nephropathy patients in cardiac structure and function at the beginning of hemodialysis and their impact on the prediction of mortality

Journal of International Medical Research ◽

10.1177/0300060521997588 ◽

2021 ◽

Vol 49 (3) ◽

pp. 030006052199758

Author(s):

Chao Tang ◽

Han Ouyang ◽

Jian Huang ◽

Jing Zhu ◽

Xiaosong Gu

Keyword(s):

Diabetic Nephropathy ◽

Diastolic Dysfunction ◽

Peak Velocity ◽

Structure And Function ◽

Cardiac Valve ◽

Cardiac Structure ◽

Prediction Of Mortality ◽

Cardiac Structure And Function ◽

Lv Diastolic Dysfunction ◽

And Function

Objectives To characterize differences in cardiac structure and function in hemodialysis (HD) patients with diabetic nephropathy (DN) and in those without using echocardiography and to determine their impact on the prediction of mortality using echocardiographic parameters. Methods Clinical, laboratory, and echocardiographic data were collected from patients commencing HD. Results Compared with those without DN, patients with DN had lower peak velocity of the early diastolic wave (e′), larger left atria, and higher peak early diastolic velocity (E)/e′ and peak velocity of tricuspid regurgitation (TR). In addition, a larger proportion of DN patients had a combination of left ventricular (LV) diastolic dysfunction, cardiac valve calcification, moderate-to-severe cardiac valve regurgitation (CVR), and at least moderate pericardial effusion (PE). After accounting for age, sex, smoking, hypertension, hemoglobin, and albumin, DN was responsible for e′ < 10 cm/s, E/e′ >13 m/s, TR >2.8 m/s, LV diastolic dysfunction, CVR, and PE. LV diastolic dysfunction and E/e′ >13 were the most useful predictors of mortality in patients with DN. Conclusions Patients with DN who undergo HD tend to have worse LV diastolic function and are more likely to have heart valve problems. LV diastolic dysfunction and E/e′ are predictors of death in DN patients.

Download Full-text